Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Westlake › NPI 1841264868
Hospital

University Hospitals ST. John Medical Center

University Hospitals ST. John Medical Center was paid $11.77M by Medicaid between Jan 2018 and Dec 2024, across 232 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoUNIVERSITY HOSPITALS ST. JOHN MEDICAL CENTER
WESTLAKE, OH 44145
33aNPI1841264868assigned 02/15/2006
28Total paid$11.77M
24GClaims358,747
24DCodes billed232
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#68 of 101
Median peer was paid$22.32M
This provider vs. median0.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201826,535$896K
201920,395$714K
202018,926$822K
202127,174$1.16M
202233,012$1.40M
2023140,730$4.26M
2024incomplete91,975$2.51M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 20,388 18,861 $2.54M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 12,546 11,327 $1.76M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 12,788 10,969 $1.57M
96361 Intravenous infusion, hydration; each additional hour 7.6% 2,920 2,169 $892K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.3% 2,864 2,299 $625K
70450 Computed tomography, head or brain; without contrast material 4.8% 2,637 2,122 $561K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.5% 2,394 2,200 $289K
71275 Computed tomographic angiography, chest, with contrast material 1.9% 959 731 $220K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.8% 4,041 3,572 $212K
80053 Comprehensive metabolic panel 1.7% 27,179 22,661 $206K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 1,561 1,153 $198K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.4% 871 495 $163K
220 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.4% 2,340 $161K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.2% 770 $145K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.2% 1,695 $137K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.1% 1,597 $129K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 881 $109K
99213 Doctor's office visit, returning patient (routine) <1% 1,067 $108K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 737 $97K
G0378 Hospital observation service, per hour <1% 1,810 $90K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,902 $82K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 682 $80K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 426 $77K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 807 $71K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 447 $68K
92550 <1% 611 $65K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 456 $60K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 267 $60K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 26,348 $55K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 16,699 $49K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,352 $39K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 3,315 $34K
84484 <1% 12,914 $34K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,086 $33K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 443 $31K
71046 Radiologic examination, chest; 2 views <1% 1,729 $31K
92557 <1% 612 $31K
62323 <1% 73 $30K
76642 <1% 366 $26K
71045 Radiologic examination, chest; single view <1% 6,997 $23K
97161 <1% 694 $22K
76000 <1% 391 $22K
77063 Screening digital breast tomosynthesis, bilateral <1% 486 $20K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 176 $16K
93971 <1% 253 $16K
36415 Collection of venous blood by venipuncture <1% 15,911 $15K
86850 <1% 885 $15K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 644 $15K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,052 $14K
93975 <1% 110 $14K
97165 <1% 411 $13K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 133 $13K
80048 Basic metabolic panel (calcium, ionized) <1% 2,300 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,231 $12K
97535 Self-care/home management training, each 15 minutes <1% 555 $12K
82805 <1% 559 $12K
74018 <1% 556 $12K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,416 $12K
72125 Computed tomography, cervical spine; without contrast material <1% 1,039 $11K
82728 <1% 616 $11K
85027 <1% 4,328 $11K
20610 <1% 60 $10K
73564 <1% 512 $10K
76830 Ultrasound, transvaginal <1% 371 $9K
96367 <1% 281 $9K
73030 <1% 521 $9K
73130 <1% 499 $9K
84443 Thyroid stimulating hormone (TSH) <1% 1,279 $9K
86900 <1% 915 $8K
73630 <1% 590 $8K
83540 <1% 640 $7K
83735 <1% 4,599 $6K
83550 <1% 638 $6K
73610 <1% 446 $5K
82947 <1% 4,386 $5K
77067 Screening mammography, bilateral, including computer-aided detection <1% 488 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,666 $5K
12001 <1% 39 $5K
84702 <1% 3,078 $5K
80320 <1% 327 $5K
72110 <1% 71 $5K
82607 <1% 187 $4K
86140 <1% 699 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 5,343 $4K
96376 <1% 1,519 $4K
76982 <1% 117 $4K
80061 Lipid panel <1% 356 $4K
73110 <1% 223 $4K
90715 <1% 273 $4K
72100 <1% 142 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,001 $3K
97116 <1% 233 $3K
70486 <1% 97 $3K
J1815 Injection, insulin, per 5 units <1% 106 $3K
72131 <1% 68 $3K
93970 <1% 29 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 14 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 15 $3K
81003 <1% 5,447 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 113 $3K
80069 <1% 495 $3K
82247 <1% 143 $3K
A9270 Non-covered item or service <1% 8,648 $2K
99152 <1% 512 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 146 $2K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 167 $2K
83690 <1% 4,176 $2K
87081 <1% 142 $2K
76536 <1% 13 $2K
76770 <1% 15 $2K
81001 <1% 5,249 $2K
77062 <1% 55 $2K
83605 <1% 2,410 $2K
12011 <1% 13 $1K
99215 Doctor's office visit, returning patient (complex) <1% 14 $1K
87040 <1% 1,215 $1K
85610 <1% 3,891 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,379 $1K
86901 <1% 915 $1K
73502 <1% 92 $1K
83655 <1% 34 $1K
71250 <1% 16 $1K
83880 <1% 1,387 $1K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 799 $1K
93017 <1% 16 $1K
97162 <1% 34 $1K
83615 <1% 166 $1K
73562 <1% 16 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 602 $1K
J3490 Unclassified drugs <1% 1,715 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 251 $970.43
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 356 $950.63
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 96 $880.62
77065 Tomosynthesis, mammo <1% 31 $879.24
99153 Mod sedat endo service >5yrs <1% 34 $859.72
80143 <1% 761 $841.81
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 291 $807.20
85379 <1% 1,202 $733.80
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,927 $712.78
82077 <1% 587 $700.83
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 96 $669.80
81025 <1% 1,791 $666.54
85652 <1% 310 $650.25
J7030 Infusion, normal saline solution , 1000 cc <1% 5,219 $639.94
85730 <1% 707 $588.15
J1650 Injection, enoxaparin sodium, 10 mg <1% 967 $574.21
87634 <1% 488 $552.44
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,710 $546.23
82533 <1% 14 $523.16
94729 <1% 14 $515.98
94726 <1% 12 $515.98
77066 Tomosynthesis, mammo <1% 95 $510.44
84100 <1% 491 $457.70
80179 <1% 745 $403.16
G0404 Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination <1% 128 $373.13
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 1,282 $360.91
73090 <1% 51 $340.68
83525 <1% 14 $328.81
87077 <1% 317 $320.21
73140 <1% 29 $288.24
84132 <1% 545 $286.09
82378 <1% 15 $274.76
82330 <1% 478 $265.30
87075 <1% 548 $249.14
85007 <1% 92 $237.81
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,082 $233.56
87205 <1% 158 $222.41
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 1,054 $202.29
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 14 $200.38
87186 <1% 327 $195.92
C9113 Injection, pantoprazole sodium, per vial <1% 120 $189.15
J1644 Injection, heparin sodium, per 1000 units <1% 876 $172.30
85018 <1% 499 $165.96
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,532 $158.96
82550 <1% 341 $156.34
82248 <1% 16 $124.73
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,647 $115.46
73080 <1% 14 $112.46
82435 <1% 387 $108.69
J7999 Compounded drug, not otherwise classified <1% 397 $99.20
87070 <1% 64 $97.68
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 898 $88.10
J2704 Injection, propofol, 10 mg <1% 1,941 $76.30
87800 <1% 15 $72.96
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,364 $69.06
J1030 Injection, methylprednisolone acetate, 40 mg <1% 239 $68.04
84295 <1% 391 $67.04
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 119 $65.26
80329 <1% 100 $64.18
73590 <1% 27 $59.57
J8540 Dexamethasone, oral, 0.25 mg <1% 394 $59.48
J3475 Injection, magnesium sulfate, per 500 mg <1% 413 $58.66
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 780 $52.88
J2060 Injection, lorazepam, 2 mg <1% 156 $38.35
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,027 $36.49
J3370 Injection, vancomycin hcl, 500 mg <1% 46 $36.34
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,464 $35.78
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 550 $32.60
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 242 $27.28
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 117 $26.48
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 399 $25.54
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 464 $24.68
J0690 Injection, cefazolin sodium, 500 mg <1% 181 $19.92
A4217 Sterile water/saline, 500 ml <1% 158 $18.26
94761 <1% 561 $11.66
J1040 Injection, methylprednisolone acetate, 80 mg <1% 178 $10.93
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 35 $10.40
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 179 $10.26
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 32 $7.20
J0780 Injection, prochlorperazine, up to 10 mg <1% 15 $7.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 381 $6.31
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 314 $5.28
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 338 $3.74
J7060 5% dextrose/water (500 ml = 1 unit) <1% 95 $3.69
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 129 $3.57
J3480 Injection, potassium chloride, per 2 meq <1% 15 $3.39
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 20 $3.31
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 229 $3.29
J1171 Injection, hydromorphone, 0.1 mg <1% 105 $2.84
J7050 Infusion, normal saline solution, 250 cc <1% 101 $2.04
J1596 Injection, glycopyrrolate, 0.1 mg <1% 64 $0.33
94760 0% 344 $0.00
C1769 Guide wire 0% 89 $0.00
76377 0% 115 $0.00
87449 0% 174 $0.00
72128 0% 18 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 13 $0.00
86308 0% 14 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 58 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 126 $0.00
00731 0% 56 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 56 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Same official

Other billing entities under SCHILLERO, ANTHONY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.